STAR*D: what have we learned?
Rush
A John
AJ
D000553:Ambulatory Care; D000928:Antidepressive Agents / Q000627:therapeutic use*; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D003511:Cyclohexanols / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000523:psychology; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D018020:Lithium Compounds / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data*; D012107:Research Design / Q000706:statistics & numerical data; D055502:Secondary Prevention; D014191:Tranylcypromine / Q000627:therapeutic use; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
D000928:Antidepressive Agents; D003511:Cyclohexanols; D018020:Lithium Compounds; D014191:Tranylcypromine; D000069470:Venlafaxine Hydrochloride